RxDoctor Payments Data

Brian Foulk

Family Medicine · Cherry Tree, PANPI 1245262591

Payments from drug & device makers

$1,818in general payments, 2019–2025

Across 148 payments — averaging $12.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$308
  • Johnson & Johnson$189
  • Boehringer Ingelheim$188
  • Amgen$168
  • Pfizer$165
  • Lilly USA, LLC$150
  • plus $651 from 14 others

What the payments were for

  • Food & beverage$1,79899%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,818 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide158$245,800
EliquisApixaban108$124,430
JardianceEmpagliflozin65$85,934
TrulicityDulaglutide67$70,779
FarxigaDapagliflozin Propanediol42$61,552
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$40,934
MounjaroTirzepatide28$32,458
Synjardy XrEmpagliflozin/Metformin Hcl31$28,277
XareltoRivaroxaban21$26,942
TradjentaLinagliptin27$26,130
ProliaDenosumab14$23,953
JanuviaSitagliptin Phosphate14$21,419
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$20,155
Tresiba Flextouch U-200Insulin Degludec15$16,486
Janumet XrSitagliptin Phos/Metformin Hcl19$14,787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$308$245,800158 claims
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Jentadueto Xr$188$151,284137 claims
PfizerEliquis$165$124,430108 claims
Lilly USA, LLCTrulicity, Mounjaro$150$103,23795 claims
AstraZenecaFarxiga$116$61,55242 claims
GSKTrelegy Ellipta, Anoro Ellipta$48$61,08955 claims
MerckJanuvia, Janumet Xr$27$36,20633 claims
Johnson & JohnsonXarelto$189$26,94221 claims
AmgenProlia$168$23,95314 claims
Astellas Pharma US IncMyrbetriq$42$9,80618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Cherry Tree

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →